Literature DB >> 9814862

Antiretroviral drugs and the central nervous system.

R H Enting, R M Hoetelmans, J M Lange, D M Burger, J H Beijnen, P Portegies.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9814862     DOI： 10.1097/00002030-199815000-00005

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  49 in total

1.  Lopinavir measurement in pleural effusion in a human immunodeficiency virus type 1-infected patient with kaposi's sarcoma.

Authors:  Marta Boffito; Patrick G Hoggard; David J Back; Stefano Bonora; Agostino Maiello; Anna Lucchini; Giovanni Di Perri
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

2.  In vitro and Ex vivo Neurotoxic Effects of Efavirenz are Greater than Those of Other Common Antiretrovirals.

Authors:  Vincent T Ciavatta; Edyta K Bichler; Iris A Speigel; Courtney C Elder; Shavonne L Teng; William R Tyor; Paul S García
Journal:  Neurochem Res       Date:  2017-08-02       Impact factor: 3.996

Review 3.  Indinavir: a review of its use in the management of HIV infection.

Authors:  G L Plosker; S Noble
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

4.  Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy.

Authors:  Tracy Fischer-Smith; Sidney Croul; Aderonke Adeniyi; Katarzyna Rybicka; Susan Morgello; Kamel Khalili; Jay Rappaport
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

5.  Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticles.

Authors:  Supriya D Mahajan; Indrajit Roy; Gaixia Xu; Ken-Tye Yong; Hong Ding; Ravikumar Aalinkeel; Jessica Reynolds; Donald Sykes; Bindukumar B Nair; Elaine Y Lin; Paras N Prasad; Stanley A Schwartz
Journal:  Curr HIV Res       Date:  2010-07       Impact factor: 1.581

6.  HIV-1 CNS in vitro infectivity models based on clinical CSF samples.

Authors:  Borja Mora-Peris; Alan Winston; Lucy Garvey; Laura J Else; Robin J Shattock; Carolina Herrera
Journal:  J Antimicrob Chemother       Date:  2015-10-15       Impact factor: 5.790

7.  Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS.

Authors:  Kenneth Williams; Susan Westmoreland; Jane Greco; Eva Ratai; Margaret Lentz; Woong-Ki Kim; Robert A Fuller; John P Kim; Patrick Autissier; Prahbat K Sehgal; Raymond F Schinazi; Norbert Bischofberger; Michael Piatak; Jeffrey D Lifson; Eliezer Masliah; R Gilberto González
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

Review 8.  Neuropsychiatric complications of antiretroviral therapy.

Authors:  Michelle S Cespedes; Judith A Aberg
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 9.  Towards nanomedicines for neuroAIDS.

Authors:  Vidya Sagar; Sudheesh Pilakka-Kanthikeel; Ravi Pottathil; Shailendra K Saxena; Madhavan Nair
Journal:  Rev Med Virol       Date:  2014-01-07       Impact factor: 6.989

10.  Neuroprotective activities of CEP-1347 in models of neuroAIDS.

Authors:  Dawn Eggert; Prasanta K Dash; Santhi Gorantla; Huanyu Dou; Giovanni Schifitto; Sanjay B Maggirwar; Stephen Dewhurst; Larisa Poluektova; Harris A Gelbard; Howard E Gendelman
Journal:  J Immunol       Date:  2009-12-04       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.